Cargando…

Development of a Bioactive Polymeric Drug Eluting Coronary Stent Coating Using Electrospraying

Drug-eluting stents are now routinely used in the treatment of acute coronary syndromes caused by coronary artery disease. Whilst the sustained release of anti-proliferative drugs from these devices has greatly reduced the need for repeat revascularisation procedures, this approach is not suitable f...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKittrick, C. M., Cardona, M. J., Black, R. A., McCormick, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928095/ https://www.ncbi.nlm.nih.gov/pubmed/31441008 http://dx.doi.org/10.1007/s10439-019-02346-6

Ejemplares similares

Modelling the Impact of Atherosclerosis on Drug Release and Distribution from Coronary Stents
por: McKittrick, C. M., et al.
Publicado: (2015)

Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)

Release mechanism and parameter estimation in drug-eluting stent systems: analytical solutions of drug release and tissue transport
por: McGinty, Sean, et al.
Publicado: (2015)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Succinobucol-Eluting Stents Increase Neointimal Thickening and Peri-Strut Inflammation in a Porcine Coronary Model
por: Watt, Jonathan, et al.
Publicado: (2013)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2022)

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
por: Funayama, Naohiro, et al.
Publicado: (2022)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents
por: Akinapelli, Abhilash, et al.
Publicado: (2017)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Fabrication of Polymeric Coatings with Controlled Microtopographies Using an Electrospraying Technique
por: Guo, Qiongyu, et al.
Publicado: (2015)

Five-Year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome: A Meta-Analysis
por: Daoud, Frederic C., et al.
Publicado: (2023)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis
por: Daoud, Frederic C., et al.
Publicado: (2022)

Synthesis and Appraisal of Natural Drug-Polymer-Based Matrices Relevant to the Application of Drug-Eluting Coronary Stent Coatings
por: Ghafoor, Bakhtawar, et al.
Publicado: (2020)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Development of biodegradable zein-based bilayer coatings for drug-eluting stents
por: Lenzuni, Martina, et al.
Publicado: (2021)

Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent
por: Barkholt, Trine Ø., et al.
Publicado: (2019)

Coronary Stent Thrombosis: Current Insights into New Drug-Eluting Stent Designs
por: Kim, Hyun Kuk, et al.
Publicado: (2012)

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis
por: Fujita, Hiroshi, et al.
Publicado: (2014)

Exploring alternatives to drug-eluting stents: the potential of combining drug coated balloon with bare-metal stents
por: Murai, Kota, et al.
Publicado: (2023)

Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study
por: Pellegrini, Dario, et al.
Publicado: (2023)

Evolving Coronary Stents Coated With New Bioactive Agents
por: Choi, Yunseok
Publicado: (2011)

Drug-eluting coronary stents – focus on improved patient outcomes
por: Jaffery, Zehra, et al.
Publicado: (2011)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
por: Kim, Minsu, et al.
Publicado: (2023)

Extended Outcomes of Complex Coronary Disease in the Drug Eluting Stent Era
por: Desrosiers, Kevin P., et al.
Publicado: (2011)

In vivo angioscopy evaluation of drug-eluting stent occlusion treated with drug-coated balloon
por: Horikoshi, Takeo, et al.
Publicado: (2023)

Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents Compared With Drug-Coated Balloons: A Retrospective Outlook
por: Sharif Khan, Hamid, et al.
Publicado: (2020)

Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
por: Her, Ae-Young, et al.
Publicado: (2023)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration
por: Wang, Jing, et al.
Publicado: (2020)

3D printing of drug-eluting bioactive multifunctional coatings for orthopedic applications
por: Adarkwa, Eben, et al.
Publicado: (2023)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Coronary Aneurysm Occurring Late after Drug-Eluting Stent Implantation
por: Abergel, Etan, et al.
Publicado: (2011)

Novel drug-eluting stents in the treatment of de novo coronary lesions
por: Capodanno, Davide, et al.
Publicado: (2011)

Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis
por: Yin, Rui-Xing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9gb7b6pao9rvogurcilq1j0rih